ALNY Articles, Alnylam Pharmaceuticals Inc.
home / stock / alny / alny articles
-
Over the past twenty days of trading, Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), from November 07, 2019 to December 05, 2019 there is a potential...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
– First and Only FDA-approved Treatment Demonstrating Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – AMVUTTRA Met Primary and All Secondary Endpoints, with Significant Improvement in Polyneuropathy, Quality o...
-
- Cemdisiran Treatment Resulted in a 37 Percent Mean Reduction in 24-Hour Urine Protein to Creatinine Ratio , Relative to Placebo – a Key Prognostic Marker of Progression to End-Stage Kidney Disease in Patients with IgA Nephropathy - - Acceptable Safety Prof...
-
– Lumasiran Demonstrated Evidence of Improvements in Exploratory Endpoints of Systemic Oxalosis, Including Echocardiographic Structure and Function, Nephrocalcinosis, and Kidney Stone Events – – Expands Upon Previously Reported Reductions in Plasma Oxalate...
User Article Content Posts are Active
Member Article Content Creation is Now Live!
The member article and content must reference a US or Canadian Stock Symbol. You can search for a stock symbol for reference.
Menu Example
Login or Sign Up and proceed to the create article section
Information on earning more coins or to purchase coins click here